MYDECINE

“Buzz on the Street” Show: Mydecine Innovations Group Telehealth Platform

← Back to all news
June 17, 2020

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth Platform.”

Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO) (formerly New Leaf Brands Inc.) is pleased to announce that it has signed a definitive share exchange agreement with Mindleap Health Inc. (“Mindleap”) for the acquisition of a 100% interest in MindLeap’s Digital Telehealth Platform focused on the emerging psychedelics industry.

Mydecine Innovation’s Group is a life sciences company focused on the development and commercialization of products and services that contribute to improving overall health and wellbeing. The company’s mission is to create a healthier world through advanced technologies, natural products, and psychedelic derived medicines. Mydecine Innovations Group owns a group of trailblazing companies that are focused on helping millions of people live better lives and our portfolio includes:

  • Cannabis & Fungi Based Products
  • Mycology Research & Development
  • Disruptive Technology
  • Therapeutic Treatment Facilities
  • Large-Scale Distribution
  • Psychedelic-Derived Medicines
  • For more information, please visit: Mydecine Innovations Group Inc.